Home > Insider Trading > Filing (0001753926-24-001570)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1919246	Chromocell Therapeutics Corp	CHRO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1433316	Ii Knuettel Francis	C/O Chromocell Therapeutics Corporation 4400 Route 9 South, Suite 1000 Freehold NJ 07728	Ceo, Pres., Cfo, Treas & Secty	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-09-10	6,500	$0.89	537,010	No	4	P	Indirect	By Lara Knuettel Revocable Trust
Common Stock	Acquisiton	2024-09-11	5,500	$0.94	542,510	No	4	P	Indirect	By Lara Knuettel Revocable Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Lara Knuettel Revocable Trust
No	4	P	Indirect	By Lara Knuettel Revocable Trust

Footnotes

This transaction is being reported to reflect the purchase of these shares by the Lara Knuettel Revocable Trust, of which the Reporting Person is co-trustee and has individual dispositive power. This sale price represents the weighted average sale price of the shares purchased ranging from $0.80 to $0.92 per share, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This transaction is being reported to reflect the purchase of these shares by the Lara Knuettel Revocable Trust, of which the Reporting Person is co-trustee and has individual dispositive power. This sale price represents the weighted average sale price of the shares purchased ranging from $0.89 to $0.98 per share, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.